ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Clinuvel Pharmaceuticals Ltd

Clinuvel Pharmaceuticals Ltd (UR9)

6.955
-0.285
(-3.94%)
Closed February 03 4:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
6.955
Bid
6.885
Ask
7.02
Volume
12,071
6.78 Day's Range 7.00
0.00 52 Week Range 0.00
Previous Close
7.24
Open
6.895
Last Trade
430
@
6.92
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

UR9 Latest News

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

MELBOURNE, Australia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- CLINUVEL has filed a New Drug Submission (NDS) to Health Canada, seeking approval for its novel photoprotective therapy SCENESSE®...

Afamelanotide in fair-skinned Parkinson’s patients

MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or...

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE®...

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists...

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

UV, HEV protection for individuals at high risk of photoageing and skin cancer MELBOURNE, Australia, March 01, 2023 (GLOBE NEWSWIRE) -- CLINUVEL (ASX: CUV) (Börse Frankfurt: UR9) (ADR Level...

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

MELBOURNE, Australia, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Executive summaryPositive Results in the Half Year to 31 December 2022 19% increase in revenues from clinical demand for SCENESSE®...

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have shown that the drug afamelanotide can reduce critical skin damage caused by ultraviolet...

CLINUVEL Trial Results Show Drug Reduces DNA Damage

MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair disorder show that a new drug – afamelanotide – may be able to reduce the...

CLINUVEL progresses vitiligo treatment program

MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder vitiligo will undergo further studies in North America this year. The drug...

Positive final results in stroke

 ASX: XETRA-DAX:  Level 1 ADR:CUV UR9 CLVLY  EXECUTIVE SUMMARY afamelanotide evaluated as safe in mild to moderate arterial ischaemic stroke (NIHSS 1–15, n=6)NIHSS1 scores improved in five...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

UR9 - Frequently Asked Questions (FAQ)

What is the current Clinuvel Pharmaceuticals share price?
The current share price of Clinuvel Pharmaceuticals is 6.955 €
What is the 1 year trading range for Clinuvel Pharmaceuticals share price?
Clinuvel Pharmaceuticals has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
3510LiveOne Inc
42.59 €
(2,920.57%)
943
3XUHuijing Holdings Co Ltd
0.003 €
(50.00%)
33.5k
RFC4Copaur Minerals
0.146 €
(39.05%)
353.53k
CY1KSBF AG
3.66 €
(38.64%)
25.24k
K8DWellfield Technologies Inc
0.0162 €
(37.29%)
160.27k
E3O1Nexoptic Technology Corp
0.008 €
(-46.67%)
9.12k
Y92Trilogy AI Corp
0.0925 €
(-41.46%)
3.07k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
3k
D4GDataMetrex AI Ltd
0.0032 €
(-38.46%)
224k
C1ZCentury Lithium Corp
0.1235 €
(-34.13%)
23.86k
D7GNel ASA
0.1914 €
(-5.25%)
7.85M
3CPXiaomi Corporation
4.832 €
(-0.91%)
2.09M
M11First Graphene Limited
0.0358 €
(1.70%)
2.04M
76M0Realbotix Corp
0.34 €
(36.00%)
1.8M
DMLSayona Mining Limited
0.0149 €
(-3.87%)
1.48M

Discussion

View Full Feed
JustGoDeep JustGoDeep 2 minutes ago
That Is Utter, Complete And Total Nonsense!!
BIEL
delerious1 delerious1 3 minutes ago
News tomorrow at 9AM....could be wrong and could be right but above all best to ignore the noise, they've been wrong all along....shorts are scared and getting desperate
NBRI
PickStocks PickStocks 4 minutes ago
Libor is not the bottleneck........
COOP
dinogreeves dinogreeves 5 minutes ago
Kazzy this is great news, either this week, next week or two weeks after that, we have waited this long, 3 years for me now, the hard part is done, now we wait for the permits, contracts, then FID and albeit the hardest part of all these years of waiting and waiting is the merger.

Y
TGLO
janice shell janice shell 5 minutes ago
Who admitted to that?
Carjockey2 Carjockey2 5 minutes ago
I sure am counting..and in disbelief.

If you made some $$$ while posting 4,399 post I would bother counting..now I am laughing out loud.

300,000% gains.. the biggest gainer ever on the OTC and you're telling me obviously by not answering my question about you making any
HMBL
bigbux1 bigbux1 5 minutes ago
Nice, 'Wright said his first priority is to expand domestic energy production including liquefied natural gas..'
TGLO
jbsliverer jbsliverer 5 minutes ago
I thought that was a requirement option. One of the checkboxes for two of the above sort of thing. Beat your wife or kids, rape, white supremists, kill a puppy, and so forth. Loyalty to the crime lord is a given before the questionair. More than two gets to the top of the list.

ht
mrMadMax mrMadMax 6 minutes ago
🤡Look at this Clown's rage! Do you lose money daily with your OTC market "facts," or have you struck it rich? Who's manipulating things? The only manipulation is in your stupid head; you don't understand a thing about what's happening in this market. You're out of your mind and out of touch
ATMH
janice shell janice shell 6 minutes ago
How ironic that Trump and Musk want to deregulate everything here.
delerious1 delerious1 7 minutes ago
Every call that he makes is wrong...hope folks know this by now...and his buddies too
GVSI
newmedman newmedman 7 minutes ago
Well, the GOP just confirmed the guy who tried to take all their federal grants away from them and is behind all the shenanigans that Elon is up to at the moment.

Expect Mr Vought to produce more hijinks, hilarity and nonstop flurry of lawsuits for the foreseeable future. idiotsǶ
janice shell janice shell 8 minutes ago
We'll see.
TenKay TenKay 8 minutes ago
Actually #4395….

But who’s counting….

Oh that’s right…you!

LOLOLOLOSSIMO!!! 😉
HMBL
janice shell janice shell 8 minutes ago
Yes, I think you're right about all of that.
jondoeuk jondoeuk 9 minutes ago
There are other bi-specific CARs, including two by GILD's Kite, and at least one tri-specific in development as well.

CRGX's CRG-023 (IND cleared, PhI mid-year) is the first tri-specific CAR-T to express three independent CARs from a single vector, with each CAR having a distinct co-
CRGX
jondoeuk jondoeuk 10 minutes ago
What they don't say is equally as important as what they do say.

Prizlon-cel, is a novel CD19/CD20 bispecific CAR-T. Of the 48 patients infused, 44 had LBCL. No patient experienced a DLT. CRS occurred in 93.8% of patients, with only one case of grade 3. ICANS occurred in 6.3% of patie
CRS
janice shell janice shell 10 minutes ago
Yes, you're right. I must have clicked on that accidentally.
BDEZ BDEZ 10 minutes ago
It's just seething resentment towards White people

https://x.com/LaurenWitzkeDE/status/1886522854877094058
BDEZ BDEZ 11 minutes ago
Got it thanks...
1jas 1jas 11 minutes ago
Oldstocks. I want to thank you for all the extra work you've been putting in, getting us as much info as you do.
AFFU
dinogreeves dinogreeves 11 minutes ago
The far left always play into the far right hands. Just like the bishop at the Cathedral uttering to the President to have "Mercy".
SMCI

Your Recent History

Delayed Upgrade Clock